ATC Abstracts

American Transplant Congress abstracts

2016 American Transplant Congress » Concurrent Session: Kidney: Desensitization

Date: Monday, June 13, 2016

Time: 4:30pm-6:00pm

Location: Room 304

Session Type: Concurrent Session

Meeting: 2016 American Transplant Congress

4:30pm-4:42pm
A Prospective Carfilzomib-Based Desensitization Trial: Phase 1 Results.

S. Tremblay,1 A. Shields,1 R. Alloway,1 P. Brailey,1 B. Abu Jawdeh,1 T. Latif,1 J. Driscoll,1 M. Pando,2 A. Girnita,1 E. Woodle.1

4:42pm-4:54pm
Long-Term Assessment of the Safety and Efficacy of IVIG and Rituximab-Based Desensitization (DES).

J. Choi, J. Kahwaji, A. Vo, S. Louie, A. Kang, A. Peng, R. Villicana, D. Puliyanda, I. Kim, S. Jordan.

4:54pm-5:06pm
Impact of the New Kidney Allocation System (KAS) on Transplant Rates & Outcomes in Broadly-HLA Sensitized (HS) Patients Transplanted After Desensitization (DES).

A. Vo,1 X. Zhang,2 S. Williamson,1 K. Myers,1 N. Reinsmoen,2 J. Choi,1 J. Kahwaji,1 A. Peng,1 R. Villicana,1 S. Jordan.1

5:06pm-5:18pm
Survival Benefit of Living Donor ABOi Kidney Transplantation.

A. Massie, B. Lonze, S. Anjum, X. Luo, D. Segev.

5:18pm-5:30pm
Incidence & Impact of De Novo DSA (dnDSA) Formation on Transplant Outcomes in HLA-Sensitized (HS) Patients Transplanted After IVG+Rituximab Desensitization (DES).

A. Vo,1 J. Choi,1 J. Kahwaji,1 J. Mirocha,2 A. Peng,1 R. Villicana,1 S. Jordan.1

5:30pm-5:42pm
RNAseq Transcriptome Analysis of Bone Marrow CD138+ Plasma Cell Responses to Carfilzomib Monotherapy Desensitization.

J. Driscoll, B. Aronow, S. Tremblay, R. Alloway, E. Woodle.

5:42pm-5:54pm
Anti-Angiotensin II Type 1 Receptor Antibody Reduction with Proteasome Inhibitor-Based Desensitization.

A. Girnita, E. Portwood, P. Brailey, S. Tremblay, R. Alloway, E. Woodle.

« View all sessions from the 2016 American Transplant Congress